| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1097-0045(199610)29:4<261::AID-PROS7>3.0.CO;2-E |
| P698 | PubMed publication ID | 8876709 |
| P2093 | author name string | Stein U | |
| Aumüller G | |||
| Bonkhoff H | |||
| Remberger K | |||
| P2860 | cites work | Quantitative assessment of endogenous testicular and adrenal sex steroids and of steroid metabolizing enzymes in untreated human prostatic cancerous tissue | Q67922211 |
| Carcinoma of the prostate | Q68177742 | ||
| Intratissular androgens in benign prostatic hyperplasia and prostatic cancer | Q68983598 | ||
| Combined histologic grading of prostatic carcinoma | Q70366754 | ||
| Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate | Q72105368 | ||
| Immunocytochemical localization of human 5 alpha-reductase 2 with polyclonal antibodies in androgen target and non-target human tissues | Q72363502 | ||
| Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism | Q24311401 | ||
| Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications | Q34243006 | ||
| Neuroendocrine differentiation in human prostatic carcinoma | Q35226787 | ||
| Prostatic intraepithelial neoplasia: a premalignant lesion | Q35313484 | ||
| Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement | Q36473965 | ||
| Regulation of prostate growth | Q36796127 | ||
| The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications | Q39749785 | ||
| Morphologic and endocrine aspects of prostatic function | Q40146776 | ||
| Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model | Q40971854 | ||
| The androgen receptor: functional structure and expression in transplanted human prostate tumors and prostate tumor cell lines | Q41710235 | ||
| Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate: simultaneous demonstration of cell-specific epithelial markers | Q42475559 | ||
| The proliferative function of basal cells in the normal and hyperplastic human prostate | Q42475611 | ||
| Widespread distribution of nuclear androgen receptors in the basal cell layer of the normal and hyperplastic human prostate | Q42510111 | ||
| Androgen receptors in endocrine-therapy-resistant human prostate cancer. | Q54296309 | ||
| Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate | Q67701823 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 261-267 | |
| P577 | publication date | 1996-10-01 | |
| P1433 | published in | The Prostate | Q7758608 |
| P1476 | title | Differential expression of 5 alpha-reductase isoenzymes in the human prostate and prostatic carcinomas | |
| P478 | volume | 29 |
| Q34887797 | 5alpha-Reductase inhibitor treatment of prostatic diseases: background and practical implications |
| Q44610274 | 5α-Reductase Type 1 Immunostaining is Enhanced in Some Prostate Cancers Compared With Benign Prostatic Hyperplasia Epithelium |
| Q24815477 | Acquisition of androgen independence by human prostate epithelial cells during arsenic-induced malignant transformation |
| Q48827236 | Androgens modulate gene expression and specific DNA methylation pattern of steroid 5α-reductases in the frog Silurana tropicalis |
| Q42821805 | Biology and natural history of prostate cancer and the role of chemoprevention |
| Q33943526 | Clinical application of 5alpha-reductase inhibitors |
| Q42467745 | Comparative study of glycoconjugates of the rat prostatic lobes by lectin histochemistry |
| Q42936023 | Dysplasia of human prostate CD133(hi) sub-population in NOD-SCIDS is blocked by c-myc anti-sense |
| Q74815800 | Effect of the 5α-Reductase Inhibitor PNU 156765, Alone or in Combination with Flutamide, in the Dunning R3327 Prostatic Carcinoma Model in Rats |
| Q74597862 | Effect of the dual 5α-reductase inhibitor Pnu 157706 on the growth of dunning R3327 prostatic carcinoma in the rat |
| Q40454416 | Effects of 5 alpha reductase inhibitors on androgen-dependent human prostatic carcinoma cells. |
| Q34313221 | Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation |
| Q37828063 | Estrogen and androgen signaling in the pathogenesis of BPH. |
| Q34772459 | Estrogen receptor beta in the prostate |
| Q38296539 | Expression of 5alpha-reductases in human epithelial ovarian cancer: its correlation with androgen receptor status |
| Q34360616 | Human prostate cancer risk factors |
| Q38239520 | Impact of alpha blockers, 5-alpha reductase inhibitors and combination therapy on sexual function. |
| Q40154021 | Importance of the intracrine metabolism of adrenal androgens in androgen-dependent prostate cancer |
| Q44785091 | In vivo and in vitro effect of androstene derivatives as 5α-reductase type 1 enzyme inhibitors |
| Q52080650 | Kinetic analysis of LY320236: competitive inhibitor of type I and non-competitive inhibitor of type II human steroid 5alpha-reductase |
| Q34491450 | Molecular action of androgen in the normal and neoplastic prostate |
| Q34106904 | Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status |
| Q44817262 | Neuroendocrine differentiation in prostate cancer. An unrecognized and therapy-resistant phenotype |
| Q51766798 | New ester derivatives of dehydroepiandrosterone as 5α-reductase inhibitors |
| Q34469844 | PNU 157706, a novel dual type I and II5α-reductase inhibitor |
| Q34736918 | Prostatic stem cells |
| Q33623428 | Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases |
| Q42451991 | Relation between Bcl-2, cell proliferation, and the androgen receptor status in prostate tissue and precursors of prostate cancer |
| Q21285041 | The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases |
| Q41017464 | The 5alpha-reductase in the central nervous system: expression and modes of control |
| Q37449808 | Understanding the epidemiology, natural history, and key pathways involved in prostate cancer |
| Q81288149 | [Neuroendocrine differentiation in prostate cancer: an unrecognized and therapy resistant phenotype] |
Search more.